期刊文献+

HPLC-荧光检测法测定美托洛尔的血药浓度 被引量:4

Determination of Serum Concentration of Metoprolol by HPLC-Fluorescence Detection Method
原文传递
导出
摘要 目的:建立以高效液相色谱-荧光检测法测定美托洛尔血药浓度的方法。方法:色谱柱为Symmetry C18,流动相为乙腈-水-三乙胺-磷酸(110:390:2.5:1.6),荧光检测波长为激发波长(Ex)=265nm、发射波长(Em)=298nm,流速为0.8mL.min-1,进样量为20μL。结果:美托洛尔血药浓度在2.0~100.0μg.L-1范围内线性关系良好(r=0.9996);低、中、高3种浓度的平均相对回收率分别为99.73%、98.21%、99.38%,日内RSD分别为2.89%、2.36%、1.32%,日间RSD分别为3.73%、3.03%、2.25%,最低检测限为1.0μg.L-1。结论:本方法精密、准确、特异性强、回收率高、操作简便,适用于临床血药浓度监测及药动学研究。 OBJECTIVE: To establish a HPLC- fluorescence detection method for the determiniation of the serum concentration of metoprolol. METHODS: The determination was performed on Symmetry C18 column, and the mobile phase consisted of acetonitrile- water triethylamine -phosphoric acid (110 : 390 : 2.5 : 1.6) at a flow rate of 0.8 mL ·min^-1 The excitation wavelength was 265 nm and the emission wavelength 298 nm, and the sample size was 20μL. RESULTS: Good linearity was obtained for metoprolol over the range of 2.0-100.0 μg · L^-1 with correlation coefficient r = 0.999 6. At low, medium and high concentrations, the average recoveries of metoprolol were 99.73%, 98.21% and 99.38%, respectively. The intra- day RSD were 2.89%, 2.36% and 1.32%, respectively, and the inter- day RSD were 3.73%, 3.03% and 2.25% respectively. The lowest detectable limit was 1.0μg · L^-1. CONCLUSION: This method is precise, accurate, specific, simple yet with high recovery, and it is applicable for clinical monitoring of blood concentration and pharmacokinetie study.
机构地区 天津市儿童医院
出处 《中国药房》 CAS CSCD 北大核心 2008年第29期2272-2273,共2页 China Pharmacy
关键词 美托洛尔 高效液相色谱-荧光检测法 血药浓度 Metoprolol HPLC - fluorescence detection method Blood drug concentration
  • 相关文献

参考文献3

二级参考文献7

共引文献26

同被引文献20

  • 1徐婷娟,魏伟,徐维平,肖峰,汪庆童,吴成义,杨昭毅.酒石酸美托洛尔缓释片人体相对生物利用度研究[J].中国新药杂志,2006,15(14):1206-1209. 被引量:6
  • 2王静,付良青,关勇彪,方翼,刘泽源.酒石酸美托洛尔片人体生物利用度和生物等效性研究[J].中国临床药理学与治疗学,2006,11(9):1043-1047. 被引量:13
  • 3Pautler DB,Jusko WJ. Determination of metoprolol and alpha-hydrox- ymetoprolol in plasma by high- performance liquid chromatography[J]. J Chrom, 1982,228 : 215 - 222.
  • 4Delamoye M. Simultaneous determination of thirteen [beta ] -blockers and one metabolite by gradient high - performance liquid chromatography with photodiode - array U V detection[ J]. Fore Sci Inter,2004,141 (1) :23 - 31.
  • 5Koytchev R. Influence of the cytochrome P4502D6 * 4 allele on the phar- macokineties of controlled - release metoprolol[J]. Eur J Clin Pharmacol, 1998,54(6) :469 - 474.
  • 6LI J, YANG H L. New formulation of metoprolol-Betaloc XR[ J].中南药学,2007,5(6):571-573.
  • 7DEY N S, MA J,RAO M. Muhiparticulate drug delivery systems for controlled release[J]. Trop J Pharm Res , 2008, 7(3) :1067-1075.
  • 8WANG J X, LIN J Y. Determination of metoprolol in human plas- ma by HPLC [J]. 中外医疗,2009(16):104-105.
  • 9KOYTCHEY R. Influence of the cytochrome P4502D6 * 4 allele on the pharmacokinetics of controlled-release metoprolol [ J ]. Eur J Clin Pharm, 1998,54(6) : 469-474.
  • 10董淑英,童旭辉,李见春,吴华璞,蒋志文.液相色谱-串联质谱法测定美托洛尔缓释片的人体药动学及生物等效性[J].中国新药与临床杂志,2008,27(6):429-433. 被引量:7

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部